P2B-095

State Health Centre Oncology Department (Budapest, Hungary) › P2B-095

P2B-095

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
State Health Centre Oncology Department (Budapest, Hungary) · Dr. Clarke
consented 2013-03-30

completed

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 3 anaemia with onset in cycle 4 (2013-06-28); assessed as related to study drug (probable); resolved 2013-07-05; action: drug withdrawn.

severe assessed

Grade 2 diarrhoea with onset in cycle 4 (2013-06-19); assessed as not related to study drug (unlikely); resolved 2013-06-22.

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.